NIH-funded research R01 grant

How aging affects natural antibodies from a special B cell type and why it matters for older adults

Official title: The Role of Biological Sex in the Self-renewal of B1 Cells into Old Age in Mice and Humans

Funded at Western Michigan Univ School of Medicine · NIH-11361634 · Data updated 2026-11-12

This NIH grant explores how aging changes a specific B cell type that makes natural antibodies, which could influence how well older people are protected from infections.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWestern Michigan Univ School of Medicine
NIH-funded
Lab location1 site (Kalamazoo, United States)
Project startSeptember 15, 2024
Project endMay 31, 2029
Funding year2026
Award (this year)$766,255
NIH project number5R01AG084752-03
Project IDNIH-11361634 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants are adults aged 65 and older, including both sexes, who can contribute samples and information related to immune function.

Less likely to help

Some older adults with different health issues or medications may not experience direct benefits from these basic science findings.

What this research studies

The project looks at B1 cells and their ability to renew themselves as people age, and how this affects natural immunity in both men and women. Researchers will study immune cells from older adults and compare them with younger groups to see how self-renewal and antibody production differ. The work aims to connect basic biology with real-aged immune function to inform healthier aging. By understanding why protective natural antibodies decline in some older individuals, this research could point toward strategies to maintain immune protection later in life.

Why it matters

Potential benefit: If successful, the findings could guide new approaches to preserve immune defense in the elderly, potentially reducing infection risk.

How similar studies have gone: Previous work shows sex-specific differences in natural antibody protection with age, suggesting that this line of research could yield meaningful insights.

Where this research is happening

  • Western Michigan Univ School of Medicine
    Kalamazoo, United States
    Active

Researchers

  • Principal investigator: Holodick, Nichol Elizabeth — Western Michigan Univ School of Medicine
  • Study coordinator: Holodick, Nichol Elizabeth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.